Travis Gries
Family · Cincinnati, OHNPI 1891239802
Payments from drug & device makers
Across 100 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$745
- Almatica Pharma LLC$568
- AbbVie$275
- Merck$122
- Lilly USA, LLC$107
- GSK$102
- plus $419 from 14 others
What the payments were for
- Food & beverage$2,339100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 17 | $745 |
| Almatica Pharma LLC | 23 | $568 |
| AbbVie | 16 | $275 |
| Merck | 8 | $122 |
| Lilly USA, LLC | 7 | $107 |
| GSK | 6 | $102 |
| Exact Sciences | 4 | $74 |
| Neurocrine Biosciences, Inc. | 4 | $59 |
| Viiv Healthcare Company | 2 | $45 |
| Hologic Sales And Service, LLC | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Boehringer Ingelheim | 1 | $26 |
| AstraZeneca | 1 | $23 |
| Abbott | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Verona Pharma, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,339 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 105 | $112,001 |
| JanuviaSitagliptin Phosphate | 67 | $45,356 |
| JardianceEmpagliflozin | 49 | $41,528 |
| EliquisApixaban | 42 | $27,832 |
| Spiriva HandihalerTiotropium Bromide | 45 | $24,631 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 44 | $24,105 |
| Breo ElliptaFluticasone/Vilanterol | 51 | $21,088 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 21 | $16,601 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $16,232 |
| Incruse ElliptaUmeclidinium Bromide | 36 | $15,535 |
| Spiriva RespimatTiotropium Bromide | 27 | $15,510 |
| Aimovig AutoinjectorErenumab-Aooe | 13 | $13,694 |
| OzempicSemaglutide | 12 | $11,695 |
| Arnuity ElliptaFluticasone Furoate | 37 | $11,032 |
| EntrestoSacubitril/Valsartan | 16 | $10,932 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $107 | $112,001105 claims |
| GSKAnoro Ellipta, Breo Ellipta, Trelegy Ellipta, Incruse Ellipta, Arnuity Ellipta | $102 | $87,993191 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat | $26 | $73,64097 claims |
| MerckJanuvia | $122 | $45,35667 claims |
| Novo NordiskOzempic | $20 | $11,69512 claims |
| AstraZenecaSymbicort | $23 | $8,95433 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.
Other family in Cincinnati
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Lindsey SpencerCincinnati$53K
- Bria BarjucaCincinnati$38K
- Jillian CowanCincinnati$20K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.